Dermatofibrosarcoma protuberans: Clinical, pathological, and genetic (COL1A1-PDGFB) study with therapeutic implications

Histopathology

Volumn 54, Issue 7, 2009, Pages 860-872

  Llombart, Beatriz ^a,d,e   Sanmartín, Onofre ^a   López Guerrero, Jose Antonio ^b   Monteagudo, Carlos ^e   Serra, Carlos ^a   Requena, Celia ^a   Poveda, Andrés ^c   Vistós, Juan Luis ^a   Almenar, Sergio ^d   Llombart Bosch, Antonio ^e   Guillén, Carlos ^a  

^a Department of Dermatology ^*  (Spain)

^b Laboratory of Molecular Biology   (United States)

^c Departments of Oncology

^d INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

Author keywords

COL1A1 PDGFB fusion gene; Dermatofibrosarcoma protuberans; Fibrosarcoma; Imatinib mesylate; Myoid; Sclerosing

Indexed keywords

CD34 ANTIGEN; COLLAGEN; COLLAGEN TYPE 1 ALPHA 1; IMATINIB; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER RECURRENCE; CHEMOSURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; FIBROSARCOMA; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HISTIOCYTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; COLLAGEN TYPE I; DERMATOFIBROSARCOMA; DNA PRIMERS; FEMALE; GENE FUSION; GENES, SIS; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; PIPERAZINES; PYRIMIDINES; SKIN NEOPLASMS; YOUNG ADULT;

MYOIDA;

EID: 66949157235     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03310.x     Document Type: Article

References (69)

1. Gloster HM Jr. Dermatofibrosarcoma protuberans. J. Am. Acad. Dermatol. 1996 35 355 374.
2. Huether MJ, Zitelli JA, Brodland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J. Am. Acad. Dermatol. 2001 44 656 659. (Pubitemid 32249525)
3. Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer 2004 101 28 38. (Pubitemid 38812420)
4. Nouri K, Lodha R, Jimenez G, Robins P. Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience. Dermatol. Surg. 2002 28 1060 1064. (Pubitemid 35424808)
5. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 1962 15 717 725.
6. Sanmartin O, Llombart B, Lopez-Guerrero JA, Serra C, Requena C, Guillen C. Dermatofibrosarcoma protuberans. Actas Dermosifiliogr. 2007 98 77 87. (Pubitemid 46714846)
7. Aiba S, Tabata N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br. J. Dermatol. 1992 127 79 84.
8. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J. Am. Acad. Dermatol. 1993 28 613 617. (Pubitemid 23104238)
9. Goldblum JR. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch. Pathol. Lab. Med. 1995 119 238 241.
10. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am. J. Dermatopathol. 1993 15 429 434. (Pubitemid 23303044)
11. Cohen PR, Rapin RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa. Am. J. Dermatopathol. 1994 16 573 574. (Pubitemid 24323366)
12. Kahn HJ, Fekete E, From L. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. Hum. Pathol. 2001 32 50 56. (Pubitemid 32150628)
13. Fisher C. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. Ultrastruct. Pathol. 2004 28 291 305. (Pubitemid 39657535)
14. Hanft VN, Shea CR, McNutt NS, Pullitzer D, Horenstein MG, Prieto VG. Expression of CD34 in sclerotic ("plywood") fibromas. Am. J. Dermatopathol. 2000 22 17 21. (Pubitemid 30109077)
15. McNiff JM, Subtil A, Cowper SE, Lazova R, Glusac EJ. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans. J. Cutan. Pathol. 2005 32 413 418. (Pubitemid 40853003)
16. Diwan AH, Horenstein MG. Dermatofibrosarcoma protuberans association with nuchal-type fibroma. J. Cutan. Pathol. 2004 31 62 66. (Pubitemid 38130278)
17. Li N, McNiff J, Hui P, Manfioletti G, Tallini G. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. Am. J. Dermatopathol. 2004 26 267 272. (Pubitemid 38989021)
18. Pedeutour F, Simon MP, Minoletti F et al. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res. 1995 55 2400 2403.
19. Terrier-Lacombe MJ, Guillou L, Maire G et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data - a study from the French Federation of Cancer Centers Sarcoma Group. Am. J. Surg. Pathol. 2003 27 27 39. (Pubitemid 36014896)
20. Navarro M, Simon MP, Migeon C, Turc-Carel C, Pedeutour F. COL1A1-PDGFB fusion in a ring chromosome 4 found in a dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 1998 23 263 266. (Pubitemid 28465644)
21. Sandberg AA, Anderson WD, Fredenberg C, Hashimoto H. Dermatofibrosarcoma protuberans of breast. Cancer Genet. Cytogenet. 2003 142 56 59. (Pubitemid 36349264)
22. Llombart B, Sanmartin O, Lopez-Guerrero JA et al. Analysis of the COL1A1-PDGFB fusion gene in a case of dermatofibrosarcoma protuberans with a fibrosarcoma component. Actas Dermosifiliogr. 2006 97 337 341. (Pubitemid 44125134)
23. O'Brien KP, Seroussi E, Dal Cin P et al. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 1998 23 187 193. (Pubitemid 28402346)
24. Wang J, Hisaoka M, Shimajiri S, Morimitsu Y, Hashimoto H. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Diagn. Mol. Pathol. 1999 8 113 119. (Pubitemid 29521901)
25. Saeki H, Tamada Y, Watanabe D et al. Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans. Clin. Exp. Dermatol. 2006 31 441 444.
26. Gokden N, Dehner LP, Zhu X, Pfeifer JD. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR. J. Cutan. Pathol. 2003 30 190 195. (Pubitemid 36428428)
27. Maire G, Fraitag S, Galmiche L et al. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans. Arch. Dermatol. 2007 143 203 210. (Pubitemid 46294585)
28. Patel KU, Szabo SS, Hernandez VS et al. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum. Pathol. 2008 39 184 193.
29. McArthur GA, Demetri GD, van Oosterom A et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J. Clin. Oncol. 2005 23 866 873. (Pubitemid 46224187)
30. Penner DW. Metastasizing dermatofibrosarcoma protuberans; a case report. Cancer 1951 4 1083 1086.
31. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am. J. Surg. Pathol. 1998 22 576 587. (Pubitemid 28213745)
32. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am. J. Surg. Pathol. 1992 16 921 925.
33. Shmookler BM, Enzinger FM, Weiss SW. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 1989 64 2154 2161. (Pubitemid 19280419)
34. Maeda T, Hirose T, Furuya K, Shirakawa K, Kobayashi K. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report. Mod. Pathol. 1998 11 491 495. (Pubitemid 28224453)
35. Jha P, Moosavi C, Fanburg-Smith JC. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger. Ann. Diagn. Pathol. 2007 11 81 88. (Pubitemid 46349793)
36. Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study. Am. J. Surg. Pathol. 1985 9 630 639. (Pubitemid 16196277)
37. Puig L, De Moragas JM, Matias-Guiu X, Moreno A. Pigmented dermatofibrosarcoma protuberans (Bednar's tumor). Med. Cutan. Ibero. Lat. Am. 1988 16 314 318.
38. Bisceglia M, Vairo M, Calonje E, Fletcher CD. Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature. Pathologica 1997 89 264 273. (Pubitemid 127777503)
39. Calonje E, Fletcher CD. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases. J. Cutan. Pathol. 1996 23 30 36. (Pubitemid 26070624)
40. Diaz-Cascajo C. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant. J. Cutan. Pathol. 1997 24 197 198.
41. Sanz-Trelles A, Ayala-Carbonero A, Rodrigo-Fernandez I, Weil-Lara B. Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans. J. Cutan. Pathol. 1998 25 44 49. (Pubitemid 28059594)
42. Fletcher CD, Evans BJ, MacArtney JC, Smith N, Wilson Jones E, McKee PH. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology 1985 9 921 938. (Pubitemid 16191935)
43. Orlandi A, Bianchi L, Spagnoli LG. Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. J. Cutan. Pathol. 1998 25 386 393. (Pubitemid 28425467)
44. Lambert WC, Abramovits W, Gonzalez-Sevra A, Souchon E, Schwartz RA, Little WP Jr. Dermatofibrosarcoma non-protuberans: description and report of five cases of a morpheaform variant of dermatofibrosarcoma. J. Surg. Oncol. 1985 28 7 11. (Pubitemid 15169286)
45. Zelger BW, Ofner D, Zelger BG. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans. Histopathology 1995 26 519 527.
46. Young CR III., Albertini MJ. Atrophic dermatofibrosarcoma protuberans: case report, review, and proposed molecular mechanisms. J. Am. Acad. Dermatol. 2003 49 761 764. (Pubitemid 37210305)
47. Barr FJ, Golitz LE, Siongco A. Sclerotic dermatofibrosarcoma protuberans - a lesion which may confused with sclerotic fibroma. In: 31th Annual Meeting American Society of Dermatopathology, San Francisco, California, 18 20, March, 1997 (Abstr.).
48. Diaz-Cascajo C, Weyers W, Borghi S. Sclerosing dermatofibrosarcoma protuberans. J. Cutan. Pathol. 1998 25 440 444. (Pubitemid 28474856)
49. Sabater-Marco V, Perez-Valles A, Berzal-Cantalejo F, Rodriguez-Serna M, Martinez-Diaz F, Martorell-Cebollada M. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int. J. Dermatol. 2006 45 59 62.
50. Llatjos R, Fernandez-Figueras MT, Diaz-Cascajo C, Ribera M, Ariza A. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases. Histopathology 2000 37 452 455.
51. Banerjee SS, Harris M, Eyden BP, Hamid BN. Granular cell variant of dermatofibrosarcoma protuberans. Histopathology 1990 17 375 378. (Pubitemid 20318981)
52. Maire G, Pedeutour F, Coindre JM. COL1A1-PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant. Am. J. Surg. Pathol. 2002 26 932 937. (Pubitemid 34747647)
53. Llombart B, Sanmartin O, Requena C et al. Atrophic dermatofibrosarcoma protuberans with the fusion gene COL1A1-PDGFB. J. Eur. Acad. Dermatol. Venereol. 2008 22 371 374. (Pubitemid 351247436)
54. Takahira T, Oda Y, Tamiya S et al. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans. Mod. Pathol. 2007 20 668 675. (Pubitemid 46788873)
55. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 2003 37 1 19. (Pubitemid 36417917)
56. Bianchini L, Maire G, Guillot B et al. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion. Virchows Arch. 2008 452 689 696.
57. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet. Cytogenet. 2003 140 1 12. (Pubitemid 36110633)
58. Shimizu A, O'Brien KP, Sjoblom T et al. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 1999 59 3719 3723. (Pubitemid 29381878)
59. Leevers SJ, Vanhaesebroeck B, Waterfield MD. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 1999 11 219 225. (Pubitemid 29164037)
60. Musashi M, Ota S, Shiroshita N. The role of protein kinase C isoforms in cell proliferation and apoptosis. Int. J. Hematol. 2000 72 12 19.
61. Heldin CH, Eriksson U, Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys. 2002 398 284 290. (Pubitemid 34848597)
62. Rubin BP, Schuetze SM, Eary JF et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol. 2002 20 3586 3591. (Pubitemid 34983217)
63. Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int. J. Cancer 2002 100 623 626. (Pubitemid 34832970)
64. Mizutani K, Tamada Y, Hara K et al. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans. Br. J. Dermatol. 2004 151 235 237. (Pubitemid 39061309)
65. Price VE, Fletcher JA, Zielenska M et al. Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans. Pediatr. Blood Cancer 2005 44 511 515. (Pubitemid 40614501)
66. Liu YC, Chen SC, Chang C, Leu CM, Hu CP. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines. Exp. Cell Res. 1996 228 206 211. (Pubitemid 26384650)
67. Funa K, Ahgren A. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA. Cell Growth Differ. 1997 8 861 869. (Pubitemid 27355459)
68. Joensuu H, Roberts PJ, Sarlomo-Rikala M et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 2001 344 1052 1056. (Pubitemid 32267975)
69. Greco A, Roccato E, Miranda C, Cleris L, Formelli F, Pierotti MA. Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement. Int. J. Cancer 2001 92 354 360. (Pubitemid 32249711)